Koo Foundation Sun Yat-Sen Cancer Center (和信治癌中心醫院) Market Research Report

Background

Overview

Established in 1988, the Koo Foundation Sun Yat-Sen Cancer Center (KFSYSCC) is Taiwan's first and only specialty cancer hospital, dedicated exclusively to cancer care, research, and education. Located in Taipei City, the center operates as a non-profit institution with a mission to prevent and cure cancer by providing expert and compassionate care, deepening the understanding of cancers prevalent among its patients, and training the next generation of oncologic and healthcare professionals. Its vision is to reduce the burden of cancer and improve human health as a globally trusted leader in cancer care, research, quality improvement, and education.

Mission and Vision

• Mission: To prevent and cure cancer by providing expert and compassionate care, deepen understanding of cancers to which patients are especially vulnerable, and train the next generation of oncologic and healthcare professionals.

• Vision: To reduce the burden of disease from cancer and improve health in humankind as a globally trusted leading institution in cancer care, research, quality improvement, and education.

Core Values

• Professional Excellence

• Compassion and Integrity

• Teamwork and Collaboration

• Patient Centeredness

Key Strategic Focus

Core Objectives

KFSYSCC aims to provide comprehensive cancer care, advance research in oncology, and offer educational programs to train healthcare professionals. The center focuses on delivering patient-centered care through a multidisciplinary approach, ensuring high-quality treatment and support services.

Areas of Specialization

• Breast Cancer

• Lung Cancer

• Colorectal Cancer

• Head & Neck Cancer

• Lymphoma

• Liver Cancer

• Thyroid Cancer

• Leukemia

• Gynecological Tumors

• Urological Tumors

Key Technologies Utilized

KFSYSCC employs advanced medical technologies and treatment modalities, including:

• State-of-the-art imaging techniques

• Targeted therapies

• Immunotherapies

• Robotic-assisted surgeries

• Comprehensive diagnostic tools

Primary Markets and Conditions Targeted

The center primarily serves patients in Taiwan and the broader Asia-Pacific region, focusing on various cancer types prevalent in these populations. It also engages in global research collaborations to address international cancer care challenges.

Financials and Funding

Funding History

As a non-profit institution, KFSYSCC's funding is derived from:

• Government grants

• Donations from individuals and organizations

• Research grants

• Revenue from medical services

Recent Funding Rounds

Specific details regarding recent funding rounds are not publicly disclosed.

Notable Investors

As a non-profit entity, KFSYSCC does not have traditional investors but receives support from various stakeholders, including:

• Government bodies

• Philanthropic organizations

• Academic institutions

Utilization of Capital

The capital is utilized for:

• Enhancing medical facilities and equipment

• Funding research initiatives

• Supporting educational programs

• Providing patient care services

Pipeline Development

Key Pipeline Candidates

KFSYSCC is involved in various research projects and clinical trials focusing on:

• Development of novel cancer therapies

• Improvement of diagnostic methods

• Enhancement of patient care protocols

Stages of Clinical Trials or Product Development

The center conducts clinical trials at various phases, including:

• Phase I: Assessing safety and dosage

• Phase II: Evaluating efficacy and side effects

• Phase III: Confirming effectiveness and monitoring adverse reactions

Target Conditions

The clinical trials target a range of cancers, such as:

• Breast Cancer

• Lung Cancer

• Colorectal Cancer

• Head & Neck Cancer

Anticipated Milestones

KFSYSCC aims to achieve:

• Successful completion of ongoing clinical trials

• Publication of research findings

• Implementation of new treatment protocols

Technological Platform and Innovation

Proprietary Technologies

KFSYSCC has developed proprietary technologies in:

• Genomic cancer research

• Tumor tissue banking

Significant Scientific Methods

The center employs:

• Advanced imaging techniques

• Molecular diagnostics

• Robotic-assisted surgeries

AI-Driven Capabilities

KFSYSCC integrates AI in:

• Diagnostic imaging analysis